Jesmin Shafiq

2.5k total citations · 1 hit paper
44 papers, 1.7k citations indexed

About

Jesmin Shafiq is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Radiation. According to data from OpenAlex, Jesmin Shafiq has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Oncology and 17 papers in Radiation. Recurrent topics in Jesmin Shafiq's work include Advances in Oncology and Radiotherapy (23 papers), Advanced Radiotherapy Techniques (17 papers) and Global Cancer Incidence and Screening (13 papers). Jesmin Shafiq is often cited by papers focused on Advances in Oncology and Radiotherapy (23 papers), Advanced Radiotherapy Techniques (17 papers) and Global Cancer Incidence and Screening (13 papers). Jesmin Shafiq collaborates with scholars based in Australia, Canada and United Kingdom. Jesmin Shafiq's co-authors include Michael Bartoň, Geoff P. Delaney, Timothy P. Hanna, Michael Frommer, Stephen R. Thompson, Shalini Vinod, Karen Wong, Susannah Jacob, Miriam M. Boxer and Steven Kao and has published in prestigious journals such as Circulation Research, Cancer and The Lancet Oncology.

In The Last Decade

Jesmin Shafiq

44 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012

2014 383 citations Michael Bartoň, Susannah Jacob et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Jesmin Shafiq

Since Specialization

Citations

This map shows the geographic impact of Jesmin Shafiq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesmin Shafiq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesmin Shafiq more than expected).

Fields of papers citing papers by Jesmin Shafiq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesmin Shafiq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesmin Shafiq. The network helps show where Jesmin Shafiq may publish in the future.

Co-authorship network of co-authors of Jesmin Shafiq

This figure shows the co-authorship network connecting the top 25 collaborators of Jesmin Shafiq. A scholar is included among the top collaborators of Jesmin Shafiq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesmin Shafiq. Jesmin Shafiq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quality of Decision-making at Oncology Multidisciplinary Team Meetings: A Structured Observational Study 2025 ·Clinical Oncology ·Yu Xuan Koo, Jesmin Shafiq, (unknown), Sarah Avery, Shalini Vinod	1
2	Cost-Outcome of Radiotherapy for Local Control and Overall Survival Benefits in Breast Cancer 2024 ·Clinical Oncology ·Anne Powell, Vikneswary Batumalai, Karen Wong, (unknown), Jesmin Shafiq, Geoff P. Delaney, Shalini Vinod	1
3	Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis 2024 ·The Lancet Oncology ·(unknown), Jesmin Shafiq, Geoff P. Delaney, Yavuz Anacak, Freddie Bray, (unknown), Soehartati Gondhowiardjo, (unknown), Tiara Bunga Mayang Permata, (unknown), (unknown), Eduardo Zubizarreta, Mei Ling Yap	8
4	Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort 2022 ·Radiation Oncology ·(unknown), Jesmin Shafiq, Matthew Field, (unknown), (unknown), Senthilkumar Gandhidasan, Eric Hau, Shalini Vinod	6
5	Translation of oncology multidisciplinary team meeting (MDM) recommendations into clinical practice 2021 ·BMC Health Services Research ·Shalini Vinod, (unknown), Sara Kim, (unknown), (unknown), Jesmin Shafiq	10
6	Surgical and radiotherapy patterns of care in the management of breast cancer in NSW and ACT Australia 2021 ·Journal of Medical Imaging and Radiation Oncology ·(unknown), Jesmin Shafiq, Patsy S. Soon, Geoff P. Delaney	4
7	Patterns of palliative radiotherapy fractionation for brain metastases patients in New South Wales, Australia 2020 ·Radiotherapy and Oncology ·Vikneswary Batumalai, Joseph Descallar, Geoff P. Delaney, (unknown), Karen Wong, Jesmin Shafiq, Shalini Vinod, Michael Bartoň	6
8	Patterns of use of palliative radiotherapy fractionation for bone metastases and 30-day mortality 2020 ·Radiotherapy and Oncology ·Vikneswary Batumalai, Joseph Descallar, Geoff P. Delaney, (unknown), Karen Wong, Jesmin Shafiq, Shalini Vinod, Michael Bartoň	9
9	Quality management in radiation therapy: A 15 year review of incident reporting in two integrated cancer centres 2020 ·Technical Innovations & Patient Support in Radiation Oncology ·(unknown), Andrew Wallis, (unknown), (unknown), Philip Vial, Jesmin Shafiq, Michael Bartoň, (unknown), Geoff P. Delaney	9
10	Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications 2020 ·Radiotherapy and Oncology ·Vikneswary Batumalai, Geoff P. Delaney, Joseph Descallar, (unknown), Karen Wong, Jesmin Shafiq, Michael Bartoň	11
11	Estimating the cost of radiotherapy for 5-year local control and overall survival benefit 2019 ·Radiotherapy and Oncology ·Vikneswary Batumalai, Karen Wong, Jesmin Shafiq, Timothy P. Hanna, (unknown), (unknown), (unknown), (unknown), (unknown), Thomas Tran, (unknown), Dion Forstner, Geoff P. Delaney, Michael Bartoň	13
12	Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia 2019 ·Radiotherapy and Oncology ·(unknown), (unknown), Jesmin Shafiq, Shalini Vinod, Michael Bartoň, Geoff P. Delaney	18
13	Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines 2016 ·Radiotherapy and Oncology ·Stephen R. Thompson, Geoff P. Delaney, Susannah Jacob, Jesmin Shafiq, Karen Wong, Timothy P. Hanna, (unknown), Michael Bartoň	9
14	Comparison of Magnetic Resonance Imaging and Computed Tomography for Breast Target Volume Delineation in Prone and Supine Positions 2016 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Geoff P. Delaney, Verity Ahern, Miriam M. Boxer, (unknown), Steven David, (unknown), Jennifer A. Harvey, Eng‐Siew Koh, Karen Lim, George Papadatos, Mei Ling Yap, Vikneswary Batumalai, Elizabeth Lazarus, (unknown), Jesmin Shafiq, Gary Liney, Catherine J. Moran, Peter Metcalfe, Lois Holloway	17
15	A Population-based Model of Local Control and Survival Benefit of Radiotherapy for Lung Cancer 2016 ·Clinical Oncology ·Jesmin Shafiq, Timothy P. Hanna, Shalini Vinod, Geoff P. Delaney, Michael Bartoň	30
16	The population benefit of radiotherapy for cervical cancer: Local control and survival estimates for optimally utilized radiotherapy and chemoradiation 2015 ·Radiotherapy and Oncology ·Timothy P. Hanna, Jesmin Shafiq, Geoff P. Delaney, Michael Bartoň	25
17	Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012 breakdown → 2014 ·Radiotherapy and Oncology ·Michael Bartoň, Susannah Jacob, Jesmin Shafiq, Karen Wong, Stephen R. Thompson, Timothy P. Hanna, Geoff P. Delaney	383
18	Estimating the Population Benefit of Radiotherapy: Using Demand Models to Estimate Achievable Cancer Outcomes 2014 ·Clinical Oncology ·Timothy P. Hanna, Jesmin Shafiq	7
19	Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases 2009 ·European Journal of Cancer ·Kristin Harris, Edward Chow, Liying Zhang, Galina Velikova, Andrea Bezjak, Jackson Wu, Michael Bartoň, Orhan Sezer, Richard Eek, Jesmin Shafiq, Albert Yee, Mark Clemons, Michael Brundage, Peter Hoskin, Yvette M. van der Linden, Colin Johnson, Andrew Bottomley	44
20	An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer 2007 ·Radiotherapy and Oncology ·Jesmin Shafiq, Geoff P. Delaney, Michael Bartoň	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact